Clinical trials
Phase 1/2 Biliary Tract Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 21 |
| Completed | 14 |
| Active, not recruiting | 7 |
| Unknown status | 7 |
| Terminated | 6 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 3 |
| AstraZeneca | 2 |
| National Cancer Institute (NCI) | 2 |
| University of Michigan Rogel Cancer Center | 2 |
| Yuhan Corporation | 2 |
| ASLAN Pharmaceuticals | 1 |
| Akeso | 1 |
| Amgen | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Avenzo Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 56 |
| Carcinoma, Non-Small-Cell Lung | 15 |
| Colorectal Neoplasms | 13 |
| Stomach Neoplasms | 13 |
| Cholangiocarcinoma | 12 |
| Endometrial Neoplasms | 11 |
| Ovarian Neoplasms | 10 |
| Neoplasm Metastasis | 8 |
| Pancreatic Neoplasms | 8 |
| Breast Neoplasms | 7 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.